[
  {
    "ts": null,
    "headline": "Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview",
    "summary": "Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to combat cancer and other serious diseases. ORLANDO, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the “Company” or “Exo Bio”), operating as a leading U.S. biotechnology company focused on exosome-based cancer therapy, announced the release of a new interview with strategic consultant Dr. Marvin Hausman, an esteemed Immunologist and Board-Certified",
    "url": "https://finnhub.io/api/news?id=78fc96078ee48ac0c45b4abd77732da1a86138c180402635886d375971c91e1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764855000,
      "headline": "Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview",
      "id": 137680197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to combat cancer and other serious diseases. ORLANDO, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the “Company” or “Exo Bio”), operating as a leading U.S. biotechnology company focused on exosome-based cancer therapy, announced the release of a new interview with strategic consultant Dr. Marvin Hausman, an esteemed Immunologist and Board-Certified",
      "url": "https://finnhub.io/api/news?id=78fc96078ee48ac0c45b4abd77732da1a86138c180402635886d375971c91e1c"
    }
  },
  {
    "ts": null,
    "headline": "Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy",
    "summary": "Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth potential. Click for this CRSP update.",
    "url": "https://finnhub.io/api/news?id=0c0fd8fef65b190bf9c8395f52f646fd5a20fb1ef943bb2877d45e24b9f1f0de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764844190,
      "headline": "Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy",
      "id": 137680924,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196575232/image_2196575232.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth potential. Click for this CRSP update.",
      "url": "https://finnhub.io/api/news?id=0c0fd8fef65b190bf9c8395f52f646fd5a20fb1ef943bb2877d45e24b9f1f0de"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Pfizer: “I Would Hold on to It”",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the company has any growth potential or if PFE is a dividend play. In response, Cramer said: “2026, yeah, there is. It’s got, they got a lot of irons in the fire. I think […]",
    "url": "https://finnhub.io/api/news?id=a6ab6b16fc9a51f20d6085c8a624a7e37a70ca5497704a0c8e60ad3455ab62a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764824700,
      "headline": "Jim Cramer on Pfizer: “I Would Hold on to It”",
      "id": 137677986,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the company has any growth potential or if PFE is a dividend play. In response, Cramer said: “2026, yeah, there is. It’s got, they got a lot of irons in the fire. I think […]",
      "url": "https://finnhub.io/api/news?id=a6ab6b16fc9a51f20d6085c8a624a7e37a70ca5497704a0c8e60ad3455ab62a2"
    }
  }
]